Veterinary Medicine Information website

Emdotrim 60 % 100 mg/g Poeder voor toediening in het drinkwater/in de melk

Authorised
  • Trimethoprim
  • Sulfadiazine sodium
Download as PDF

Product identification

Medicine name:
Emdotrim 60 % 100 mg/g Poeder voor toediening in het drinkwater/in de melk
Active substance:
  • Trimethoprim
  • Sulfadiazine sodium
Target species:
  • Cattle (calf)
  • Pig
Route of administration:
  • In drinking water/milk use

Product details

Active substance and strength:
  • Trimethoprim
    100.00
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfadiazine sodium
    543.95
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water/milk
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Cattle (calf)
      • Meat and offal
        12
        day
    • Pig
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Emdotrim 60 % 1 Box with 2000 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Box with 1000 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Box with 500 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Bag with 2000 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Bag with 1000 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Bag with 500 g Powder for use in drinking water/milk
  • Emdotrim 60 % 1 Bag with 100 g Powder for use in drinking water/milk

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V203533
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download